TY - JOUR
T1 - Kcl Test
T2 - an open-source inspired asymptomatic SARS-CoV-2 surveillance programme in an academic institution
AU - Reis de Andrade, Joana
AU - Scourfield, Edward
AU - Peswani-Sajnani, Shilpa Lekhraj
AU - Poulton, Kate
AU - Ap Rees, Thomas
AU - Khooshemehri, Paniz
AU - Doherty, George
AU - Ong, Stephanie
AU - Ivan, Iustina-Francisca
AU - Goudarzi, Negin
AU - Gardiner, Isaac
AU - Caine, Estelle
AU - Maguire, Thomas J A
AU - Leightley, Daniel
AU - Torrico, Luis
AU - Gasulla, Alex
AU - Menendez-Vazquez, Angel
AU - Ortega-Prieto, Ana Maria
AU - Pickering, Suzanne
AU - Jimenez-Guardeño, Jose M
AU - Batra, Rahul
AU - Rubinchik, Sona
AU - Tan, Aaron V F
AU - Griffin, Amy
AU - Sherrin, David
AU - Papaioannou, Stelios
AU - Trouillet, Celine
AU - Mischo, Hannah E
AU - Giralt, Victoriano
AU - Wilson, Samantha
AU - Kirk, Martin
AU - Neil, Stuart J D
AU - Galao, Rui Pedro
AU - Martindale, Jo
AU - Curtis, Charles
AU - Zuckerman, Mark
AU - Razavi, Reza
AU - Malim, Michael H
AU - Martinez-Nunez, Rocio T
N1 - © The Author(s) 2024. Published by Oxford University Press.
PY - 2024
Y1 - 2024
N2 - Rapid and accessible testing was paramount in the management of the COVID-19 pandemic. Our university established KCL TEST: a SARS-CoV-2 asymptomatic testing programme that enabled sensitive and accessible PCR testing of SARS-CoV-2 RNA in saliva. Here, we describe our learnings and provide our blueprint for launching diagnostic laboratories, particularly in low-resource settings. Between December 2020 and July 2022, we performed 158277 PCRs for our staff, students, and their household contacts, free of charge. Our average turnaround time was 16 h and 37 min from user registration to result delivery. KCL TEST combined open-source automation and in-house non-commercial reagents, which allows for rapid implementation and repurposing. Importantly, our data parallel those of the UK Office for National Statistics, though we detected a lower positive rate and virtually no delta wave. Our observations strongly support regular asymptomatic community testing as an important measure for decreasing outbreaks and providing safe working spaces. Universities can therefore provide agile, resilient, and accurate testing that reflects the infection rate and trend of the general population. Our findings call for the early integration of academic institutions in pandemic preparedness, with capabilities to rapidly deploy highly skilled staff, as well as develop, test, and accommodate efficient low-cost pipelines.
AB - Rapid and accessible testing was paramount in the management of the COVID-19 pandemic. Our university established KCL TEST: a SARS-CoV-2 asymptomatic testing programme that enabled sensitive and accessible PCR testing of SARS-CoV-2 RNA in saliva. Here, we describe our learnings and provide our blueprint for launching diagnostic laboratories, particularly in low-resource settings. Between December 2020 and July 2022, we performed 158277 PCRs for our staff, students, and their household contacts, free of charge. Our average turnaround time was 16 h and 37 min from user registration to result delivery. KCL TEST combined open-source automation and in-house non-commercial reagents, which allows for rapid implementation and repurposing. Importantly, our data parallel those of the UK Office for National Statistics, though we detected a lower positive rate and virtually no delta wave. Our observations strongly support regular asymptomatic community testing as an important measure for decreasing outbreaks and providing safe working spaces. Universities can therefore provide agile, resilient, and accurate testing that reflects the infection rate and trend of the general population. Our findings call for the early integration of academic institutions in pandemic preparedness, with capabilities to rapidly deploy highly skilled staff, as well as develop, test, and accommodate efficient low-cost pipelines.
UR - http://www.scopus.com/inward/record.url?scp=85198736884&partnerID=8YFLogxK
U2 - 10.1093/biomethods/bpae046
DO - 10.1093/biomethods/bpae046
M3 - Article
C2 - 38993523
SN - 2396-8923
VL - 9
SP - bpae046
JO - Biology Methods and Protocols
JF - Biology Methods and Protocols
IS - 1
M1 - bpae046
ER -